Drug company and scientific partners at Oxford University say there is no basis for German press report

A row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

UK lagging ‘way behind’ EU on warmer homes policy

Higher electricity prices compound the problem – as will the government’s plan…

Surrey police will not face investigation over Epsom College deaths

IOPC says no inquiry needed into force’s contact with George Pattison before…

Marmite for Vegemite: Australia’s free trade deal with the UK really is rather small beer | Greg Jericho

Trade with Britain is not the pressing issue of the moment. Scott…